Our mission is to dramatically increase survival rates and quality of life for people impacted by pancreatic cancer.
PanKind, The Australian Pancreatic Cancer Foundation, is exclusively dedicated to improving outcomes for Australians impacted by pancreatic cancer.
We are achieving results through strategic investment in ground-breaking medical research, supporting patients and carer through information and advocating for better patient outcomes.
We know from work in other cancers such as breast, skin and prostate, that medical research is the single most important factor impacting patient survival. Due to extensive funding, these cancers now have 5-year survival rates above 90%. It’s time to make the same improvements for pancreatic cancer.
We invite you to join us on the journey to improve survival rates and the quality of life for the thousands of Australians affected by this disease every year.Learn More About the Foundation
In 2017 Prof Paul Timpson and A/Prof Thomas Cox received an Avner Accelerator Grant to map and target the extracellular matrix of pancreatic cancer cells. The team have recently finished the project and have given us an update of their work.Read story ➞